院内远程缺血预适应对急性缺血性卒中脑梗死体积增长及临床结局的影响:RESCUE BRAIN随机临床试验
这项在法国11个卒中中心开展的前瞻性随机开放标签盲终点试验纳入188例发病6小时内磁共振确诊的颈动脉性缺血性卒中患者,比较标准治疗联合下肢远程缺血预适应与单纯标准治疗。
要点
- 远程缺血预适应未显著减少24小时脑梗死体积增长。
- 90天良好结局、死亡率和症状性颅内出血两组间无显著差异。
- 该辅助治疗在再灌注治疗期间或之后实施未见获益。
核心结论
- 在再灌注治疗期间或之后给予远程缺血预适应,对发病24小时脑梗死体积增长无显著影响。
研究设计与样本
- 多中心前瞻性随机开放标签盲终点概念验证试验,2015年1月12日至2018年5月2日法国11个卒中中心纳入188例发病6小时内磁共振确诊的颈动脉性缺血性卒中患者,按1:1随机分为干预组93例和对照组95例。
关键数值与推荐
- 远程缺血预适应方案:大腿袖带充气至收缩压以上110 mmHg,充气5分钟、放气5分钟,共4个循环。
- 入组患者中位NIHSS评分10分(IQR 6-16),中位基线脑梗死体积11.4 cm³(IQR 3.6-35.8 cm³);164例(87.2%)接受静脉溶栓,64例(34.0%)接受机械取栓。
临床怎么用
- 对于发病6小时内接受再灌注治疗的颈动脉性缺血性卒中患者,不推荐常规使用下肢远程缺血预适应来减少梗死体积或改善临床结局。
局限性
- 本研究为概念验证性试验,样本量有限,可能不足以检测临床结局的微小差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Treatment with remote ischemic perconditioning has been reported to reduce brain infarction volume in animal models of stroke. Whether this neuroprotective effect was observed in patients with acute ischemic stroke remains unknown. OBJECTIVE: To determine whether treatment with remote ischemic perconditioning administered to the leg of patients with acute ischemic stroke can reduce brain infarction volume growth. DESIGN, SETTING, AND PARTICIPANTS: This proof-of-concept multicenter prospective randomized open-label with blinded end point clinical trial was performed from January 12, 2015, to May 2, 2018. Patients were recruited from 11 stroke centers in France. Of the 188 patients who received magnetic resonance imaging within 6 hours of symptom onset and were confirmed to have carotid ischemic stroke, 93 were randomized to receive treatment with lower-limb remote ischemic perconditioning in addition to standard care (the intervention group), and 95 were randomized to receive standard care alone (the control group). INTERVENTIONS: Randomization on a 1:1 ratio to receive treatment with remote ischemic perconditioning (4 cycles of 5-minute inflations and 5-minute deflations to the thigh to 110 mm Hg above systolic blood pressure) in addition to standard care or standard care alone. MAIN OUTCOMES AND MEASURES: The change in brain infarction volume growth between baseline and 24 hours, measured by a diffusion-weighted sequence of magnetic resonance imaging scans of the brain. RESULTS: A total of 188 patients (mean [SD] age, 67.2 [15.7] years; 98 men [52.1%]) were included in this intention-to-treat analysis. At hospital admission, the median National Institutes of Health Stroke Scale score was 10 (interquartile range [IQR], 6-16) and the median brain infarction volume was 11.4 cm3 (IQR, 3.6-35.8 cm3); 164 patients (87.2%) received intravenous thrombolysis, and 64 patients (34.0%) underwent mechanical thrombectomy. The median increase in brain infarction growth was 0.30 cm3 (IQR, 0.11-0.48 cm3) in the intervention group and 0.37 cm3 (IQR, 0.19-0.55 cm3) in the control group (mean between-group difference on loge-transformed change, -0.07; 95% CI, -0.33 to 0.18; P = .57). An excellent outcome (defined as a score of 0-1 on the 90-day modified Rankin Scale or a score equal to the prestroke modified Rankin Scale score) was observed in 46 of 90 patients (51.1%) in the intervention group and 37 of 91 patients (40.7%) in the control group (P = .12). No significant differences in 90-day mortality were observed between the intervention and control groups (14 of 90 patients; Kaplan-Meier estimate, 15.8% vs 10 of 91 patients; Kaplan-Meier estimate, 10.4%, respectively; P = .45) or with symptomatic intracerebral hemorrhage (4 of 88 patients [4.5%] in both groups; P = .97). CONCLUSIONS AND RELEVANCE: In this study, treatment with remote ischemic perconditioning, during or after reperfusion therapies, had no significant effect on brain infarction volume growth at 24 hours after symptom onset. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02189928.
引用
- Pico F, Lapergue B, Ferrigno M, et al. Effect of In-Hospital Remote Ischemic Perconditioning on Brain Infarction Growth and Clinical Outcomes in Patients With Acute Ischemic Stroke: The RESCUE BRAIN Randomized Clinical Trial. JAMA Neurol. 2020. PMID: 32227157. doi:10.1001/jamaneurol.2020.0326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。